Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00580086 · ClinicalTrials.gov registry record
Monitoring Response to Neoadjuvant Chemotherapy by the Use of Breast Proton MR Spectroscopy
A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- 19
- Enrollment target
NCT00580086: Completed study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT00580086 is a clinical trial that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 19 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00580086 has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- 19 participants
- Enrollment target
Study Summary
This study is being done to evaluate if MR spectroscopy will give us more information about whether or not your chemotherapy will work for you. Spectroscopy is a special set of pictures taken with Magnetic Resonance Imaging (MRI) that gives us information about the chemical composition of your breast cancer.
Interventions
- OTHER MR spectroscopy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2006-11 |
| Est. Completion | 2009-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00580086
The ClinicalTrials.gov registry entry for NCT00580086 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which MR spectroscopy is the first listed.
NCT00580086 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00580086 about?
NCT00580086 is a clinical study titled "Monitoring Response to Neoadjuvant Chemotherapy by the Use of Breast Proton MR Spectroscopy". This study is being done to evaluate if MR spectroscopy will give us more information about whether or not your chemotherapy will work for you. Spectroscopy is a special set of pictures taken with Magnetic Resonance Imaging (MRI) that gives us information about the chemical composition of your breas...
What is the current status of trial NCT00580086?
This trial is currently completed. The enrollment target is 19 participants. The study started on 2006-11. Estimated completion is 2009-12.
What interventions are being tested in trial NCT00580086?
The interventions under investigation include: MR spectroscopy (OTHER).
Who is sponsoring clinical trial NCT00580086?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.